Completed trials in Ukraine: Trial Insights

Filters: Status: Completed Country / region: Ukraine Clear all

1,937 trials match Source: ClinicalTrials.gov registrations

Trials started per year
Category	Trials
2000	3
2001	6
2002	6
2003	15
2004	37
2005	37
2006	69
2007	102
2008	122
2009	104
2010	111
2011	135
2012	133
2013	101
2014	117
2015	109
2016	105
2017	131
2018	117
2019	109
2020	109
2021	89
2022	27
2023	16
2024	11
2025	6
2026	6

Trials by status
Category	Trials
Completed	1,937

Top lead sponsors
Category	Trials
AstraZeneca	90
GlaxoSmithKline	85
Boehringer Ingelheim	83
Pfizer	82
Hoffmann-La Roche	74
Sanofi	72
Janssen Research & Development, LLC	65
Bayer	48
Merck Sharp & Dohme LLC	43
Novo Nordisk A/S	40

Top conditions
Category	Trials
Diabetes Mellitus, Type 2	113
Asthma	98
Arthritis, Rheumatoid	95
Schizophrenia	72
Colitis, Ulcerative	68
Carcinoma, Non-Small-Cell Lung	60
Breast Neoplasms	59
Pulmonary Disease, Chronic Obstructive	56
Multiple Sclerosis	40
Crohn Disease	34

Trials

Showing 26 to 50 of 1,937. Each trial links to its page on Pharma Observatory.

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations NCT06040086Phase 3CompletedAstraZenecaStarted 2023
A Social Network Approach for Improving Medication Assisted Treatment and HIV Prevention and Medical Care Among People Who Inject Drugs in Ukraine NCT05824702Not applicableCompletedJohns Hopkins Bloomberg School of Public HealthStarted 2023
Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects. NCT05960240Phase 1CompletedArbutus Biopharma CorporationStarted 2023
Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations NCT05904730Phase 1CompletedLynkcell EuropeStarted 2023
Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial NCT05822583Phase 4CompletedUniversity of MinnesotaStarted 2023
Implementation a Data-to-Care Strategy to Improve HIV Continuum Outcomes for Out of Care People Living With HIV (PLWH) in Ukraine NCT05821413Not applicableCompletedJohns Hopkins Bloomberg School of Public HealthStarted 2023
CASI-Plus mHealth for Ukraine's APS Program (Aim 1) NCT06971120ObservationalCompletedUniversity of WashingtonStarted 2023
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study) NCT05804422Not applicableCompletedBogomolets National Medical UniversityStarted 2023
An Observational Study to Evaluate the Safety and Efficacy of Humacyte's HAV for Arterial Replacement or Reconstruction in Ukrainian Patients With Life or Limb-threatening Vascular Trauma NCT05873959ObservationalCompletedHumacyte, Inc.Started 2023
Simplified HCV Integrated Management Model in Methadone Clinics in Ukraine NCT07569211Not applicableCompletedUkrainian Institute on Public Health PolicyStarted 2023
Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19 NCT05639166Phase 2CompletedImmune Biosolutions IncStarted 2023
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study) NCT05770076Not applicableCompletedBogomolets National Medical UniversityStarted 2023
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 NCT05507216Phase 3CompletedAbivax S.A.Started 2023
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD). NCT05513950Phase 1CompletedChiesi Farmaceutici S.p.A.Started 2023
Study of the Safety and Efficacy of OMS906 in Patients With Paroxysmal Nocturnal Hemoglobinuria NCT05889299Phase 1CompletedOmeros CorporationStarted 2022
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 NCT05507203Phase 3CompletedAbivax S.A.Started 2022
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease NCT05499130Phase 2CompletedTeva Branded Pharmaceutical Products R&D, Inc.Started 2022
ANI-Guided Fentanyl Infusion During Living Donor Liver Resections NCT06619977Not applicableCompletedBogomolets National Medical UniversityStarted 2022
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE) NCT05514535Phase 3CompletedNovo Nordisk A/SStarted 2022
Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults NCT05422365Phase 3CompletedBiopharma Plasma LLCStarted 2022
Difficult Airway Simulation-based Training NCT05913492ObservationalCompletedBogomolets National Medical UniversityStarted 2022
Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006) NCT05298423Phase 3CompletedMerck Sharp & Dohme LLCStarted 2022
Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis NCT05374785Phase 2CompletedCelon Pharma SAStarted 2022
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2) NCT05259033Phase 3CompletedNovo Nordisk A/SStarted 2022
A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy NCT05109234Phase 3CompletedUCB Biopharma SRLStarted 2022

1,837 more trials match. See them on Pharma Observatory

Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine NCT07416448Completion date change2027-02-05 to 2026-02-05October 18, 2026
Kinematics-Based Prediction of Chronic Pain After Combat-Related Extremity Trauma NCT07432685Completion date change2027-12-14 to 2026-10-11October 18, 2026
Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine NCT07416448Status changeRecruiting to CompletedOctober 18, 2026
Kinematics-Based Prediction of Chronic Pain After Combat-Related Extremity Trauma NCT07432685Status changeEnrolling by invitation to CompletedOctober 18, 2026

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory